2m 2m 2m 2m 2m 2m 2m
ADIAL PHRMCTCLS (ADIL)
NASDAQ
$2.82-$0.01 (-0.35%)
Price as of Jul 14, 2026 4:01 AM EDT- $6.1MMarket Cap
- -69.34%1-Year Change
- BiotechnologyIndustry
ADIAL PHRMCTCLS (ADIL)
$2.82-$0.01 (-0.35%)
ADIL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $2.83 | ||
Change | +$0.05 (+1.80%) | ||
Open | $2.79 | ||
High | $2.94 | ||
Low | $2.71 | ||
Previous Close | $2.78 | ||
Volume | 53,046 | ||
30-Day Average Volume | 104,450 | ||
1-Week Change | -2.41% | ||
1-Month Change | -5.03% | ||
1-Year Change | -69.34% | ||
3-Year Change | -98.44% | ||
5-Year Change | -99.83% | ||
Fundamentals | |||
Shares Outstanding | 2.2M | ||
Total Assets | $5.2M | ||
Market Cap | $6.1M | ||
Enterprise Value | $1.5M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | N/A | ||
Free Cash Flow | -$1.6M | ||
EBIT | $0.00 | ||
EBITDA | $141.00 | ||
Net Working Capital | $3.3M | ||
EPS | -$1.48 | ||
Enterprise Value/EBITDA | 10,637 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 2 | ||
P/E | -2 | ||
PEG | N/A | ||
Price/Free Cash Flow | -4 | ||
Price/Operating Cash Flow | -4 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 25 | ||
Last Split Date | 02/06/2026 | ||
Earnings & Revenue